DeniseMAdamsMD
Pediatric Hematology & Oncology • Philadelphia, PAPediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Professor, Pediatrics, University of Pennsylvania, Children’s Hospital of Philadelphia
Dr. Adams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104
Education & Training
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of Vermont Medical CenterResidency, Pediatrics, 1989 - 1992- University of Vermont Medical CenterInternship, Transitional Year, 1988 - 1989
Georgetown University School of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 2021 - Present
VA State Medical License 2022 - 2026
DE State Medical License 2022 - 2025
NC State Medical License 2021 - 2025
NJ State Medical License 2022 - 2025
OH State Medical License 2003 - 2025
NY State Medical License 2022 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsConstitutive Activation of mTORC1 in Endothelial Cells Leads to the Development and Progression of Lymphangiosarcoma through VEGF Autocrine SignalingShaogang Sun, Song Chen, Fei Liu, Haige Wu, Jonathan B. McHugh
Cancer Cell. 2015-12-14 - 19 citationsCombined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.Michelle L Chadwick, Adam Lane, Dana Thomas, Amanda Smith, Angela R. White
Oncotarget. 2018-05-15 - 410 citationsSirolimus for the treatment of complicated vascular anomalies in children.Adrienne M. Hammill, MarySue Wentzel, Anita Gupta, Stephen C. Nelson, Anne W. Lucky
Pediatric Blood & Cancer. 2011-12-01
Press Mentions
- Targeted Therapies for Vascular Anomalies Continue to Be RefinedSeptember 3rd, 2021
CHOP Researchers Use Precision Medicine to Reverse Severe Lymphatic Disorder in a Patient with KLAOctober 5th, 2020- “Deep Sequencing” Identifies Several New Genetic Variants in Vascular AnomaliesJune 2nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
